VGLL4, TFAP2B, and WWOX have been implicated in increased body mass index, insulin resistance, lipid, and triglycerides levels and increased risk for T2D (Dennis et al. 2003; Nordquist et al. 2009; Aldaz, Ferguson, and Abba 2014). Here, TFAP2B is linked to Insulin resistance.